Loan Against Property for a Biotech Company

A biotech company requires significant funding support for research, product development, high-tech equipment, and regulatory approvals. Therefore, Loan Against Property (LAP) provides biotech companies with significant funding using their real estate assets, ensuring financial security and encouraging long-term innovation and growth.

Loan Against Property Key Features

get money icon

Loan Amount Based on Property Appraisal

interest rate

Competitive Interest Rates

flexible repayment

Flexible Loan Tenure

address document

Easy Documentation

smooth processing icon

Smooth Processing

(*T&C Applied)

Loan Against Property Advantages for Biotech Company

A Loan Against Property enables biotech companies to raise high-value funding without impacting their cash flow from operations. It is a cost-effective method of getting liquidity while continuing to own the asset.

  1. Higher loan amount based on asset value.
  2. Lower interest rates than unsecured loans.
  3. Flexible repayment terms for improved financial planning.
  4. Funds can be used for research, equipment, expansion or working capital.
  5. Retain ownership of assets while gaining liquidity.
  6. Easy process with minimal documentation
  7. Biotech-specific loan structures for tailored needs.
  8. Fast loan approval to meet urgent funding needs.

Loan Against Property Eligibility for Biotech Company

Biotech firms need to satisfy certain conditions to be eligible for a Loan Against Property to ensure smooth approval.

  1. The biotech firm should be a registered business entity
  2. Ownership of commercial or industrial property to be pledged
  3. The company must have a stable financial history
  4. Clear property title with no legal disputes
  5. Age of the borrower or key stakeholder within the eligible limits
  6. The business should be operational with consistent revenue generation
  7. Regulatory and financial compliance

Loan Against Property Documents

To simplify the loan process, we require minimal documentation.

  1. Identity proof (Aadhar, PAN, Passport, etc.)
  2. Business registration documents
  3. Property ownership documents
  4. Latest financial statements and ITR filings
  5. Bank statements for the last 6-12 months
  6. Income proof of promoters or directors
  7. Existing loan details, if any
  8. Any additional documents as per the financial institution’s requirements

Biotech Firm Loan Against Property at Terkar Capital

At Terker Capital, we understand the capital-intensive biotech industry. Our Loan Against Property solutions provide competitive terms and professional financial advisors to finance research and development, equipment acquisition, or business growth. We collaborate with biotech entrepreneurs and funding decision-makers to deliver flexible loan packages with improved interest rates, customized repayment terms, and a hassle-free process. If your biotech organization owns commercial or industrial assets, we can help unlock their full value to fund your next innovation.

Loan Against Property FAQs for Biotech Company

Commercial, industrial, or owned office spaces are typically accepted. Residential properties may also be considered in some cases.

Loan tenure typically ranges from 5 to 15 years, offering flexible repayment options.

Approval timelines vary, but with complete documentation, loans can be processed within 7-15 working days.

LAP offers lower interest rates and higher loan amounts than unsecured loans, making it a better option for biotech firms with valuable property.

No, ownership remains with you. The lender only holds the property as security until loan repayment.

No, the property must be fully owned and free from major legal disputes.

Financing the BioTech Companies in

Pune / PCMC  |  Mumbai  |  Hyderabad  |  Delhi  |  Bengaluru  |  Chennai  |  Kolkata

Terkar Capital is a registered brand of Terkar Global Financial Development Pvt Ltd, an Investment Banking Firm with a national footprint. We work extensively with professionals and businesses of all sizes to arrange debt funding instruments.

© Terkar Capital 2026

CIN: U70200PN2023PTC224016

GST No: 27AFHPT0177K1Z0

Note: All formal communication is solely via designated official emails.

We worked with